A Phase II Prospective Trial of mXELOXIRI Reintroduction for mCRC

ABSTRACT: The objective is to evaluate the efficacy and safety of reintroduction of modified XELOXIRI combined with molecular targeted drug in patients with metastatic colorectal cancer (mCRC)

DISEASE(S): Colorectal Neoplasms,Unresectable Metastatic Colorectal Carcinoma

PROVIDER: 2348455 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR